Opinion

Video

Considerations for patient follow-up after onabotA administration

Fact checked by:

An expert details key post-procedural recommendations following onabotulinumtoxinA injection for OAB.

Follow-up after onabolulinumtoxinA (Botox) injection for overactive bladder (OAB) should be tailored to the patient’s needs, according to Benjamin M. Brucker, MD.

In an interview with Urology Times®, Bruker details key post-procedural recommendations laid out in the publication, “Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.”1

“If it's a first-time injection, in my personal practice and I think many out there, we might have someone come back to see how they're doing, to check a post-void residual, usually at about 2 weeks––maybe they see a nurse or a nurse practitioner, a care navigator. Not a bad idea to have that touch point. But for my patients that have demonstrated, for example, no issues with incomplete bladder emptying, I don't necessarily tell them they have to come back for a post-void residual because they've already proven that they're not having an issue,” Brucker explained.

Brucker is a urologist and urogynecologist at NYU Langone Health in New York, New York.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      © 2025 MJH Life Sciences

      All rights reserved.